Posts Tagged ‘Diagnosis’
Dx/Rx: Liver Cancer
Product Description
Written For Oncologists, Internists, Primary Care Physicians And Any Other Health Professionals Who Care For Urologic Cancer Patients, Dx/Rx: Liver Cancer, Is A New Reference Guide To The Diagnosis And Therapy Of Liver Cancers. Organized Into A Condensed, Bulleted Format, This Pocket-Sized Reference Offers Precise And Up-To-Date Information On The Epidemiology, Classification, Diagnosis, Treatment, And Risk Factors For Cancers Of The Liver. Presented In A Handy, Easy-To-Read Format, Dx/Rx: Liver Cancer Is A Must-Have Guide For Use On The Ward Or In The Clinic.
Dx/Rx: Liver Cancer
Product Description
Written For Oncologists, Internists, Primary Care Physicians And Any Other Health Professionals Who Care For Urologic Cancer Patients, Dx/Rx: Liver Cancer, Is A New Reference Guide To The Diagnosis And Therapy Of Liver Cancers. Organized Into A Condensed, Bulleted Format, This Pocket-Sized Reference Offers Precise And Up-To-Date Information On The Epidemiology, Classification, Diagnosis, Treatment, And Risk Factors For Cancers Of The Liver. Presented In A Handy, Easy-To-Read Format, Dx/Rx: Liver Cancer Is A Must-Have Guide For Use On The Ward Or In The Clinic.
Liver Cancer: Causes, Symptoms, Signs, Diagnosis, Treatments, Stages. Everything You Need to Know About Liver Cancer
Product Description
Liver Cancer:
This book is for people who have liver cancer, as well as for their family members, friends, students, and others who want to find out more about this disease.
This booklet is only about cancer that begins in the liver. It isn’t about cancer that spreads to the liver from somewhere else.
It’s common for cancer to spread (metastasize) to the liver from the colon, lungs, breasts, or other parts of the body. When this happens, the disease is not liver cancer. Instead, the cancer in the liver is named for the organ or the tissue in which it began. For example, colon cancer that spreads to the liver is metastatic colon cancer. It is not liver cancer.
In the United States, metastatic cancer in the liver is far more common than primary liver cancer.
People with metastatic cancer in the liver have different treatment options than those with primary liver cancer. Treatment depends mainly on where the cancer started.
Product Description
Liver Cancer:
This book is for people who have liver cancer, as well as for their family members, friends, students, and others who want to find out more about this disease.
This booklet is only about cancer that begins in the liver. It isn’t about cancer that spreads to the liver from somewhere else.
It’s common for cancer to spread (metastasize) to the liver from the colon, lungs, breasts, or other parts of the body. When this happens, the disease is not liver cancer. Instead, the cancer in the liver is named for the organ or the tissue in which it began. For example, colon cancer that spreads to the liver is metastatic colon cancer. It is not liver cancer.
In the United States, metastatic cancer in the liver is far more common than primary liver cancer.
People with metastatic cancer in the liver have different treatment options than those with primary liver cancer. Treatment depends mainly on where the cancer started.
Methods of Cancer Diagnosis, Therapy, and Prognosis: Liver Cancer
Product Description
This fifth volume of the series, Methods of Cancer Diagnosis, Therapy, and Prognosis, discusses in detail the diagnosis, treatment, and prognosis of Liver Cancer. Both standard and emerging therapies for this cancer, written by expert oncologists/pathologists in this field, are included.
This fully illustrated volume:
- Is divided into 7 sections: Applications of Imaging, Resectable Liver Cancer, Unresectable Liver Cancer, Hepatocellular Cancer, Liver Colorectal Metastasis, Biliary Cancer, and Splenic Cancer.
- Discusses imaging modalities for diagnosis, treatment assessment, and prognosis.
- Includes descriptions of radial magnetic resonance imaging, helical computed tomography, magnetic resonance imaging, FDG-PET, contrast-enhanced sonography, multidetector-row computed tomography, and single photon emission computed tomography.
- Presents imaging methods for localized fibrous tumors of the liver, abdominal neoplasms, cholangiocarcinoma, gall bladder carcinoma, hepatic cellular carcinoma, extrahepatic disease, intrahepatic disease, focal liver lesions, biliary cystic tumors, extra hepatic bile duct carcinoma, and splenic metastases.
- Highlights methods for treatment of hepatocellular carcinoma (HCC) with thalidomide and transarterial treatment of hepatic malignancies.
- Discusses postoperative interferon alpha treatment of patients with HCC.
- Details the methods of immunohistochemistry, tissue microarray, and proteomic analysis for diagnosis and prognosis.
The technological advances presented in this volume are expected to expedite new discoveries and their translation to clinical practice. The field of oncology will benefit the most from these advanced methods, as a combination of therapies and personalized medicine will improve early detection of liver cancer and other cancer types.
Professor Hayat has summarized the problems associated with the complexities of research publications and has been successful in editing a must-read volume for oncologists, cancer researchers, medical teachers and students of cancer biology.
Methods of Cancer Diagnosis, Therapy, and Prognosis: Liver Cancer
Methods of Cancer Diagnosis, Therapy, and Prognosis: Liver Cancer
Product Description
This fifth volume of the series, Methods of Cancer Diagnosis, Therapy, and Prognosis, discusses in detail the diagnosis, treatment, and prognosis of Liver Cancer. Both standard and emerging therapies for this cancer, written by expert oncologists/pathologists in this field, are included.
This fully illustrated volume:
- Is divided into 7 sections: Applications of Imaging, Resectable Liver Cancer, Unresectable Liver Cancer, Hepatocellular Cancer, Liver Colorectal Metastasis, Biliary Cancer, and Splenic Cancer.
- Discusses imaging modalities for diagnosis, treatment assessment, and prognosis.
- Includes descriptions of radial magnetic resonance imaging, helical computed tomography, magnetic resonance imaging, FDG-PET, contrast-enhanced sonography, multidetector-row computed tomography, and single photon emission computed tomography.
- Presents imaging methods for localized fibrous tumors of the liver, abdominal neoplasms, cholangiocarcinoma, gall bladder carcinoma, hepatic cellular carcinoma, extrahepatic disease, intrahepatic disease, focal liver lesions, biliary cystic tumors, extra hepatic bile duct carcinoma, and splenic metastases.
- Highlights methods for treatment of hepatocellular carcinoma (HCC) with thalidomide and transarterial treatment of hepatic malignancies.
- Discusses postoperative interferon alpha treatment of patients with HCC.
- Details the methods of immunohistochemistry, tissue microarray, and proteomic analysis for diagnosis and prognosis.
The technological advances presented in this volume are expected to expedite new discoveries and their translation to clinical practice. The field of oncology will benefit the most from these advanced methods, as a combination of therapies and personalized medicine will improve early detection of liver cancer and other cancer types.
Professor Hayat has summarized the problems associated with the complexities of research publications and has been successful in editing a must-read volume for oncologists, cancer researchers, medical teachers and students of cancer biology.
Methods of Cancer Diagnosis, Therapy, and Prognosis: Liver Cancer
Methods of Cancer Diagnosis, Therapy, and Prognosis: Liver Cancer
Product Description
This fifth volume of the series, Methods of Cancer Diagnosis, Therapy, and Prognosis, discusses in detail the diagnosis, treatment, and prognosis of Liver Cancer. Both standard and emerging therapies for this cancer, written by expert oncologists/pathologists in this field, are included.
This fully illustrated volume:
- Is divided into 7 sections: Applications of Imaging, Resectable Liver Cancer, Unresectable Liver Cancer, Hepatocellular Cancer, Liver Colorectal Metastasis, Biliary Cancer, and Splenic Cancer.
- Discusses imaging modalities for diagnosis, treatment assessment, and prognosis.
- Includes descriptions of radial magnetic resonance imaging, helical computed tomography, magnetic resonance imaging, FDG-PET, contrast-enhanced sonography, multidetector-row computed tomography, and single photon emission computed tomography.
- Presents imaging methods for localized fibrous tumors of the liver, abdominal neoplasms, cholangiocarcinoma, gall bladder carcinoma, hepatic cellular carcinoma, extrahepatic disease, intrahepatic disease, focal liver lesions, biliary cystic tumors, extra hepatic bile duct carcinoma, and splenic metastases.
- Highlights methods for treatment of hepatocellular carcinoma (HCC) with thalidomide and transarterial treatment of hepatic malignancies.
- Discusses postoperative interferon alpha treatment of patients with HCC.
- Details the methods of immunohistochemistry, tissue microarray, and proteomic analysis for diagnosis and prognosis.
The technological advances presented in this volume are expected to expedite new discoveries and their translation to clinical practice. The field of oncology will benefit the most from these advanced methods, as a combination of therapies and personalized medicine will improve early detection of liver cancer and other cancer types.
Professor Hayat has summarized the problems associated with the complexities of research publications and has been successful in editing a must-read volume for oncologists, cancer researchers, medical teachers and students of cancer biology.
Methods of Cancer Diagnosis, Therapy, and Prognosis: Liver Cancer
Methods of Cancer Diagnosis, Therapy, and Prognosis: Liver Cancer
Product Description
This fifth volume of the series, Methods of Cancer Diagnosis, Therapy, and Prognosis, discusses in detail the diagnosis, treatment, and prognosis of Liver Cancer. Both standard and emerging therapies for this cancer, written by expert oncologists/pathologists in this field, are included.
This fully illustrated volume:
- Is divided into 7 sections: Applications of Imaging, Resectable Liver Cancer, Unresectable Liver Cancer, Hepatocellular Cancer, Liver Colorectal Metastasis, Biliary Cancer, and Splenic Cancer.
- Discusses imaging modalities for diagnosis, treatment assessment, and prognosis.
- Includes descriptions of radial magnetic resonance imaging, helical computed tomography, magnetic resonance imaging, FDG-PET, contrast-enhanced sonography, multidetector-row computed tomography, and single photon emission computed tomography.
- Presents imaging methods for localized fibrous tumors of the liver, abdominal neoplasms, cholangiocarcinoma, gall bladder carcinoma, hepatic cellular carcinoma, extrahepatic disease, intrahepatic disease, focal liver lesions, biliary cystic tumors, extra hepatic bile duct carcinoma, and splenic metastases.
- Highlights methods for treatment of hepatocellular carcinoma (HCC) with thalidomide and transarterial treatment of hepatic malignancies.
- Discusses postoperative interferon alpha treatment of patients with HCC.
- Details the methods of immunohistochemistry, tissue microarray, and proteomic analysis for diagnosis and prognosis.
The technological advances presented in this volume are expected to expedite new discoveries and their translation to clinical practice. The field of oncology will benefit the most from these advanced methods, as a combination of therapies and personalized medicine will improve early detection of liver cancer and other cancer types.
Professor Hayat has summarized the problems associated with the complexities of research publications and has been successful in editing a must-read volume for oncologists, cancer researchers, medical teachers and students of cancer biology.
Methods of Cancer Diagnosis, Therapy, and Prognosis: Liver Cancer
Hepatocellular Cancer: Diagnosis and Treatment
Product Description
A fully synthesized practical approach to hepatocellular cancer (HCC) patient management by members of the university of Pittsburgh’s renowned Liver Cancer Center. Their presentation includes all the latest developments in the diagnosis and treatment of primary liver cancer. A summary chapter details for physicians the diagnostic and therapeutic decision making process for dealing with such problems as incidental tumors in the liver transplant, the role of neo-adjuvant chemotherapy, intra-arterial vs. intravenous therapy, the uses of embolization, and the significance of portal vein thrombus. Authoritative and highly practical, Hepatocellular Cancer: Diagnosis and Treatment captures for physicians the recent exciting changes that in our understanding, diagnostic methods, novel therapeutics, and day-to-day management of hepatocellular cancer.
Surviving Kidney Cancer-Mayo Clinic
If you have kidney cancer, you might not experience symptoms until the disease is advanced. Not long ago, such a diagnosis was bad news. But now, thanks to technology, teamwork and medical expertise, people are beating this deadly disease.
Liver Cancer: Causes, Symptoms, Signs, Diagnosis, Treatments, Stages. Everything You Need to Know About Liver Cancer
Product Description
Liver Cancer:
This book is for people who have liver cancer, as well as for their family members, friends, students, and others who want to find out more about this disease.
This booklet is only about cancer that begins in the liver. It isn’t about cancer that spreads to the liver from somewhere else.
It’s common for cancer to spread (metastasize) to the liver from the colon, lungs, breasts, or other parts of the body. When this happens, the disease is not liver cancer. Instead, the cancer in the liver is named for the organ or the tissue in which it began. For example, colon cancer that spreads to the liver is metastatic colon cancer. It is not liver cancer.
In the United States, metastatic cancer in the liver is far more common than primary liver cancer.
People with metastatic cancer in the liver have different treatment options than those with primary liver cancer. Treatment depends mainly on where the cancer started.



